Media Resources

2018
4 April

Preventing and Treating Snakebite Envenoming
20 March

Sunshine Policies and Murky Shadows in Europe
8 March

Response to Public Consultation on EU Funds in the Area of Investment, Research & Innovation, SMEs and Single Market
12 February

SRH Commodities: Three-country comparison – Kenya, Uganda & Zambia
12 February

SRH Commodities: Data Collection Report – Zambia 2017
12 February

SRH Commodities: Data Collection Report – Uganda 2017
12 February

SRH Commodities: Data Collection Report – Kenya 2017
1 February

Statement on European Commission Proposal on Health Technology Assessments
24 January

Statement to WHO Executive Board 142: Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property
24 January

Statement to WHO Executive Board 142: Addressing the Global Shortage of, and Access to, Medicines and Vaccines
24 January

Statement to WHO Executive Board 142: Addressing the Burden of Snakebite Envenoming
2017
19 December

Pharmaceutical Marketing: Report on Education on Pharmaceutical Promotion in Medical Training
7 December

Health Action International and European Public Health Alliance Reaction to Leaked Documents from EU-Mercosur Trade Talks
5 December

Joint Letter in Reaction to Council Conclusions on FP9
1 December

Joint Letter on the Final Phases of EU-Mercosur Trade Talks
23 November

Health Action International Launches Programme to Improve Snakebite Situation in Kenya
23 November

HAI Snakebite Programme – Kenya
21 November

Recommendations on a New Model for the Provision of Scientific Advice
10 October

SRH Commodities: Measuring Prices, Availability & Affordability (Methodology & Data Entry Manual)
5 July

Pharmaceutical Promotion in Medical and Pharmacy Education in The Netherlands: Readiness for Curriculum Change
12 June

HAI & Global Snakebite Initiative Applaud WHO’s Adoption of Snakebite Envenoming as Top-level Neglected Tropical Disease
18 May

Proposed Changes to EMA’s Access to Documents Policy Fall Short on Proactive Disclosure
4 May

Joint Letter to World Health Assembly Delegates | We must delink research and development costs from cancer medicine prices
5 April

2016 Annual Report & Financial Statements
29 March

Report | The Sun Shines on Europe: transparency of financial relationships in the healthcare sector
23 March

ACCISS Study Report | Access to Insulin: Current Challenges and Constraints
20 March

Position Statement: TACD Positive Consumer Agenda – New Rules for the Global Economy
7 March

Media Release: Health Action International start een publiekscampagne tegen stijgende medicijnprijzen
7 March

Media Release: Soaring Medicine Prices the Target Of New Public Campaign Ahead Of 15 March Election
3 March

Media Statement: European Parliament Hits Target in Recommendations for Improving Access to Medicines